0001562180-19-005623.txt : 20191121
0001562180-19-005623.hdr.sgml : 20191121
20191121063247
ACCESSION NUMBER: 0001562180-19-005623
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191120
FILED AS OF DATE: 20191121
DATE AS OF CHANGE: 20191121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butler John P.
CENTRAL INDEX KEY: 0001591467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 191235675
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-11-20
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001591467
Butler John P.
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
true
true
false
false
CEO and President
Common Stock
2019-11-20
4
P
false
50000.00
3.44
A
887732.00
D
Common Stock
59928.00
I
Held by Dorothy Butler 2019 GRAT
Common Stock
31047.00
I
Held by Dorothy Butler Revocable Trust 2007
Common Stock
59928.00
I
Held by John Butler 2019 GRAT
Common Stock
31047.00
I
Held by John Butler Revocable Trust 2007
The purchase reported in this Form 4 was made on the open market.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.22 to $3.65, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Includes 1,500 shares of the Issuer's common stock purchased under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan on June 28, 2019.
/s/ Nicole R. Hadas, attorney-in-fact for John P. Butler
2019-11-21